Rate My Professor Phillip Aldridge

Dr. Phillip Aldridge serves as a Senior Lecturer in the Centre for Bacterial Cell Biology at the Biosciences Institute, Faculty of Medical Sciences, Newcastle University. He obtained his BSc degree from the University of Leicester in 1993 and his PhD from the University of Leicester in collaboration with Heidelberg University, Germany, in 1998. His early career included postdoctoral research at the Division of Molecular Microbiology, Biozentrum, University of Basel, Switzerland (1996-2000), and the Department of Microbiology at the University of Washington, Seattle, USA (2000-2003). Since 2003, he has been at Newcastle University, contributing to the Institute for Cell and Molecular Biosciences before its integration into the current structure.

Aldridge's research focuses on the molecular mechanisms governing bacterial flagellar assembly and function, particularly in pathogens like Salmonella enterica and uropathogenic Escherichia coli (UPEC). His studies investigate flagellar gene regulation, type III secretion systems, and their interactions with host innate immunity. More recently, his work has centered on urinary tract infections (UTIs), including the evolution of antibiotic resistance in clinical isolates, the role of L-form bacteria in recurrent infections, and potential non-antibiotic therapeutic strategies such as hyaluronic acid applications. Notable publications include: "Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates" (Journal of Antimicrobial Chemotherapy, 2023); "Multidrug-resistant Uro-associated Escherichia coli Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisation" (European Urology Open Science, 2022); "Possible role of L-form switching in recurrent urinary tract infection" (Nature Communications, 2019); "Two Tandem Mechanisms Control Bimodal Expression of the Flagellar Genes in Salmonella enterica" (Journal of Bacteriology, 2020); "Trimethoprim resistance in Escherichia coli exhibits an allele-specific growth advantage" (Journal of Medical Microbiology, 2025); and "Evasion of toll-like receptor recognition by Escherichia coli is mediated via population level regulation of flagellin production" (PLoS Pathogens, 2023). With thousands of citations across 77 publications, Aldridge's research has significantly influenced the fields of bacterial pathogenesis and infectious disease management.